Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis



Bin Dayel, Faten F ORCID: 0009-0006-8181-8374, Alfirevic, Ana ORCID: 0000-0002-2801-9817 and Chadwick, Amy E ORCID: 0000-0002-7399-8655
(2023) Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis. Biomedicines, 11 (5). p. 1485.

[img] PDF
biomedicines Faten Bin Dayel.pdf - Open Access published version

Download (2MB) | Preview

Abstract

<jats:p>The United States Food and Drug Administration Adverse Event Reporting System (FAERS) logged 27,140 rhabdomyolysis cases from 2004 to 31 March 2020. We used FAERS to identify 14 drugs frequently reported in 6583 rhabdomyolysis cases and to investigate whether mitochondrial toxicity is a common pathway of drug-induced rhabdomyolysis by these drugs. Preliminary screening for mitochondrial toxicity was performed using the acute metabolic switch assay, which is adapted here for use in murine L6 cells. Fenofibrate, risperidone, pregabalin, propofol, and simvastatin lactone drugs were identified as mitotoxic and underwent further investigation, using real-time respirometry (Seahorse Technology) to provide more detail on the mechanism of mitochondrial-induced toxicity. To confirm the human relevance of the findings, fenofibrate and risperidone were evaluated in primary human skeletal muscle-derived cells (HSKMDC), using the acute metabolic switch assay and real-time respirometry, which confirmed this designation, although the toxic effects on the mitochondria were more pronounced in HSKMDC. Overall, these studies demonstrate that the L6 model of acute modification may find utility as an initial, cost-effective screen for identifying potential myotoxicants with relevance to humans and, importantly, that drug-induced mitochondrial dysfunction may be a common mechanism shared by some drugs that induce myotoxicity.</jats:p>

Item Type: Article
Uncontrolled Keywords: FAERS, suspect drug-induced rhabdomyolysis, L6, HSKMDC, skeletal muscle toxicity, mitochondrial dysfunction
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 06 Jun 2023 07:14
Last Modified: 10 Jul 2023 11:20
DOI: 10.3390/biomedicines11051485
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3170837